Hubei Biocause Heilen Pharmaceutical Co., Ltd.

SZSE:301211.SZ

21.24 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income 00031.11437.38231.60131.47673.11639.92347.24224.15226.43427.96522.29731.35531.46936.52938.54637.47146.02846.028
Depreciation & Amortization 0005.3405.375.375.515.5121.7625.9114.9714.97117.9870.4849.6254.8130.449-7.014.0934.093
Deferred Income Tax 000000000000000000000
Stock Based Compensation 00000000000000000005.495.49
Change In Working Capital 0002.0290-9.79637.275-37.27506.444-7.9887.988023.067-18.362-7.8630-5.031-63.129.9029.902
Accounts Receivables 0008.386049.30727.413-27.413031.651-34.36234.3620-61.53331.256-31.2560-4.535-13.54315.79415.794
Change In Inventory 000-6.3580-59.1039.861-9.8610-25.20626.374-26.37406.21515.48723.39301.127-49.827-5.892-5.892
Change In Accounts Payables 000000000000000000000
Other Working Capital 000000000000016.852-33.84900-6.158-13.29300
Other Non Cash Items 000-8.246-21.97627.8444.176-15.538-61.18451.4931.3342.21535.842-14.8472.524-0.391-1.8246.8513.903-15.705-15.705
Operating Cash Flow 00017.52815.40554.07535.65263.088-15.752126.94231.39733.6258.83648.50316.00132.8429.89240.813-18.75649.80749.807
Investing Activities:
Investments In Property Plant And Equipment -26.764-45.303-27.329-34.577-57.221-88.367-36.133-46.278-15.754-59.035-14.375-1.774-0.767-8.12-0.871-7.783-4.292-2.443-3.189-3.876-3.876
Acquisitions Net 0000.0190.040.0890.3410.0290.00700.0430.0200.0090.87100.0092.4433.18900
Purchases Of Investments -5010-502.111-552.2350-1.4031.403-21.403000000-99.4480-290-200-21000
Sales Maturities Of Investments 22.14611.0211.00566.219100-1.74521.37400000143.493172.1370240100.017251.17700
Other Investing Activites 0.0020.0320.004-486.09611.1141.4050.341-21.3760.007-102.805-0.042-1.088-0.0420-073.489-51.034-2.443-3.189-64.977173.767
Investing Cash Flow -54.616-24.251-518.431-520.575-47.181-88.276-35.792-67.654-15.747-161.84-14.374-2.842-0.809135.37371.81873.489-51.034-102.42637.988-64.977173.767
Financing Activities:
Debt Repayment 00000000000000000-47.5-31.500
Common Stock Issued 0000000000000-11.0210000000
Common Stock Repurchased 000000000000000000000
Dividends Paid 000-138.2400-2.142-9600-72000000-0.165-0.72500
Other Financing Activities 0-1.631000-1.16802.142-0-1.087-72.0030-4.31,405.139000-00-1.863-41.616
Financing Cash Flow 0-1.6310-138.240-1.168-2.142-93.858-0-1.087-72.0030-4.31,405.139000-47.665-32.225-1.863-41.616
Other Information:
Effect Of Forex Changes On Cash 0.1491.162-0.4870.8470.5510.2981.4852.878-0.8514.7190.920.345-1.05-1.6330.119-4.5411.633-2.107-1.6680.5060.506
Net Change In Cash -48.4122.295-501.917-640.44-31.224-35.07-0.796-95.547-32.349-31.366-54.0631.12452.6761,587.38387.938-8.918-156.199-111.385-14.66-16.528182.464
Cash At End Of Period 494.73543.04520.7451,022.6621,663.1021,694.3271,729.3971,730.1921,825.7391,857.9891,889.3551,943.4151,912.2911,859.515272.13273.489-51.034105.165216.55-66.841132.151